Chongqing Pharscin Pharmaceutical Co., Ltd.

Chongqing Pharscin Pharmaceutical has over two decades of experience in R&D, production, and sales of pharmaceuticals. It holds more than sixty drug approvals—including generics and unique Chinese patent medicines—with nearly fifty included in China’s National Medical Insurance catalog. The company’s products target CNS disorders, digestive health, ENT conditions, oncology/cancer care, cardiovascular/cerebrovascular disease among others. It has received multiple national awards for quality management. Clinical results are not individually detailed publicly but the company maintains an active pipeline with at least fifteen clinical trials registered as sponsor or collaborator.